Review

You have free access to this content

Non-native protein aggregation kinetics

  1. Christopher J. Roberts*

Article first published online: 17 AUG 2007

DOI: 10.1002/bit.21627

Issue

Biotechnology and Bioengineering

Biotechnology and Bioengineering

Volume 98, Issue 5, pages 927–938, 1 December 2007

Additional Information

How to Cite

Roberts, C. J. (2007), Non-native protein aggregation kinetics. Biotechnol. Bioeng., 98: 927–938. doi: 10.1002/bit.21627

Author Information

  1. Department of Chemical Engineering, University of Delaware, Newark, Delaware 19716; telephone: 302-831-0838; fax: 302-831-1048

*Department of Chemical Engineering, University of Delaware, Newark, Delaware 19716; telephone: 302-831-0838; fax: 302-831-1048.

Publication History

  1. Issue published online: 17 OCT 2007
  2. Article first published online: 17 AUG 2007
  3. Manuscript Accepted: 6 AUG 2007
  4. Manuscript Revised: 29 JUL 2007
  5. Manuscript Received: 7 APR 2007

Funded by

  • National Institutes of Health. Grant Number: R01 EB006006

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (319K)

References

  • Andrews JM, Roberts CJ. 2007. A Lumry-Eyring nucleated-polymerization (LENP) model of protein aggregation kinetics I. Aggregation with pre-equilibrated unfolding. J Phys Chem B 111: 7897–7913.
  • Angell CA. 1982. Supercooled water. In: FranksF, editor. Water: A comprehensive treatise. New York: Plenum Press. Vol. 7, pp. 1–82.
  • Bishop MF, Ferrone FA. 1984. Kinetics of nucleation-controlled polymerization. A perturbation treatment for use with a secondary pathway. Biophys J 46(5): 631–644.
  • Bratko D, Cellmer T, Prausnitz JM, Blanch HW. 2007. Molecular simulation of protein aggregation. Biotechnol Bioeng 96(1): 1–8.
    Direct Link:
  • Buswell AM, Middelberg APJ. 2002. Critical analysis of lysozyme refolding kinetics. Biotechnol Prog 18(3): 470–475.
    Direct Link:
  • Buswell AM, Middelberg AP. 2003. A new kinetic scheme for lysozyme refolding and aggregation. Biotechnol Bioeng 83(5): 567–577.
    Direct Link:
  • Callahan MA, Xiong L, Caughey B. 2001. Reversibility of scrapie-associated prion protein aggregation. J Biol Chem 276(30): 28022–28028.
  • Chi EY, Krishnan S, Randolph TW, Carpenter JF. 2003. Physical stability of proteins in aqueous solution: Mechanism and driving forces in nonnative protein aggregation. Pharm Res 20(9): 1325–1336.
  • Chi EY, Kendrick BS, Carpenter JF, Randolph TW. 2005. Population balance modeling of aggregation kinetics of recombinant human interleukin-1 receptor antagonist. J Pharm Sci 94(12): 2735–2748.
    Direct Link:
  • Cleland JL, Wang DIC. 1990. Refolding and aggregation of bovine carbonic anhydrase B: Quasi-elastic light scattering analysis. Biochemistry 29(50): 11072–11078.
  • Colby DW, Cassady JP, Lin GC, Ingram VM, Wittrup KD. 2006. Stochastic kinetics of intracellular huntingtin aggregate formation. Nat Chem Biol 2(6): 319–323.
  • Cox DL, Lashuel H, Lee KYC, Singh RRP. 2005. The materials science of protein aggregation. MRS Bull 30(6): 452–457.
  • Cromwell ME, Hilario E, Jacobson F. 2006. Protein aggregation and bioprocessing. AAPS J 8(3): E572–E579.
  • De Young LR, Fink AL, Dill KA. 1993. Aggregation of globular proteins. Acc Chem Res 26: 614–620.
  • Debendetti PG. 1996. Metastable liquids: Concepts and principles. Princeton: Princeton University Press.
  • Dobson CM. 2004. Principles of protein folding, misfolding and aggregation. Semin Cell Dev Biol 15(1): 3–16.
  • DuBay KF, Pawar AP, Chiti F, Zurdo J, Dobson CM, Vendruscolo M. 2004. Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. J Mol Biol 341(5): 1317–1326.
  • Eisenberg D, Nelson R, Sawaya MR, Balbirnie M, Sambashivan S, Ivanova MI, Madsen AO, Riekel C. 2006. The structural biology of protein aggregation diseases: Fundamental questions and some answers. Acc Chem Res 39(9): 568–575.
  • Fernandez-Escamilla AM, Rousseau F, Schymkowitz J, Serrano L. 2004. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol 22(10): 1302–1306.
  • Ferrone F. 1999. Analysis of protein aggregation kinetics. Methods Enzymol 309: 256–274.
  • Ferrone FA, Hofrichter J, Eaton WA. 1985. Kinetics of sickle hemoglobin polymerization. I. Studies using temperature-jump and laser photolysis techniques. J Mol Biol 183(4): 591–610.
  • Fink AL. 1998. Protein aggregation: Folding aggregates, inclusion bodies and amyloid. Fold Des 3(1): R9–R23.
  • Finke JM, Roy M, Zimm BH, Jennings PA. 2000. Aggregation events occur prior to stable intermediate formation during refolding of interleukin 1b. Biochemistry 39(3): 575–583.
  • Foguel D, Robinson CR, de Sousa PC, Jr., Silva JL, Robinson AS. 1999. Hydrostatic pressure rescues native protein from aggregates. Biotechnol Bioeng 63(5): 552–558.
    Direct Link:
  • Gast K, Modler AJ, Damaschun H, Krober R, Lutsch G, Zirwer D, Golbik R, Damaschun G. 2003. Effect of environmental conditions on aggregation and fibril formation of barstar. Eur Biophys J 32(8): 710–723.
  • Goers J, Permyakov SE, Permyakov EA, Uversky VN, Fink AL. 2002. Conformational prerequisites for α-lactalbumin fibrillation. Biochemistry 41(41): 12546–12551.
  • Goldberg ME, Rudolph R, Jaenicke R. 1991. A kinetic study of the competition between renaturation and aggregation during the refolding of denatured-reduced egg white lysozyme. Biochemistry 30(11): 2790–2797.
  • Goldstein RF, Stryer L. 1986. Cooperative polymerization reactions. Analytical approximations, numerical examples, and experimental strategy. Biophys J 50(4): 583–599.
  • Grillo AO, Edwards KL, Kashi RS, Shipley KM, Hu L, Besman MJ, Middaugh CR. 2001. Conformational origin of the aggregation of recombinant human factor VIII. Biochemistry 40(2): 586–595.
  • Gsponer J, Vendruscolo M. 2006. Theoretical approaches to protein aggregation. Protein Pept Lett 13(3): 287–293.
  • Harper JD, Lansbury PT, Jr. 1997. Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 66: 385–407.
  • Hevehan DL, De Bernardez Clark E. 1997. Oxidative renaturation of lysozyme at high concentrations. Biotechnol Bioeng 54(3): 221–230.
    Direct Link:
  • Hortschansky P, Schroeckh V, Christopeit T, Zandomeneghi G, Faendrich M. 2005. The aggregation kinetics of Alzheimer's β-amyloid peptide is controlled by stochastic nucleation. Protein Sci 14(7): 1753–1759.
    Direct Link:
  • Hurshman AR, White JT, Powers ET, Kelly JW. 2004. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Biochemistry 43(23): 7365–7381.
  • Johnson SM, Wiseman RL, Sekijima Y, Green NS, Adamski-Werner SL, Kelly JW. 2005. Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: A focus on the transthyretin amyloidoses. Acc Chem Res 38(12): 911–921.
  • Jungbauer A, Kaar W. 2007. Current status of technical protein refolding. J Biotechnol 128(3): 587–596.
  • Kendrick BS, Cleland JL, Lam X, Nguyen T, Randolph TW, Manning MC, Carpenter JF. 1998. Aggregation of recombinant human interferon gamma: Kinetics and structural transitions. J Pharm Sci 87(9): 1069–1076.
    Direct Link:
  • Khurana R, Gillespie JR, Talapatra A, Minert LJ, Ionescu-Zanetti C, Millett I, Fink AL. 2001. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. Biochemistry 40(12): 3525–3535.
  • Kiefhaber T, Rudolph R, Kohler HH, Buchner J. 1991. Protein aggregation in vitro and in vivo: A quantitative model of the kinetic competition between folding and aggregation. Bio/Technology 9(9): 825–829.
  • Kurganov BI, Rafikova ER, Dobrov EN. 2002. Kinetics of thermal aggregation of tobacco mosaic virus coat protein. Biochemistry (Mosc) 67(5): 525–533.
  • Lefebvre BG, Robinson AS. 2003. Pressure treatment of tailspike aggregates rapidly produces on-pathway folding intermediates. Biotechnol Bioeng 82(5): 595–604.
    Direct Link:
  • Lefebvre BG, Gage MJ, Robinson AS. 2004. Maximizing recovery of native protein from aggregates by optimizing pressure treatment. Biotechnol Prog 20(2): 623–629.
    Direct Link:
  • Linding R, Schymkowitz J, Rousseau F, Diella F, Serrano L. 2004. A comparative study of the relationship between protein structure and β-aggregation in globular and intrinsically disordered proteins. J Mol Biol 342(1): 345–353.
  • Liu L, Murphy RM. 2006. Kinetics of inhibition of β-amyloid aggregation by transthyretin. Biochemistry 45(51): 15702–15709.
  • Lomakin A, Teplow DB, Kirschner DA, Benedek GB. 1997. Kinetic theory of fibrillogenesis of amyloid β protein. Proc Natl Acad Sci USA 94(15): 7942–7947.
  • Nichols MR, Moss MA, Reed DK, Hoh JH, Rosenberry TL. 2005. Rapid assembly of amyloid-β peptide at a liquid/liquid interface produces unstable β-sheet fibers. Biochemistry 44(1): 165–173.
  • Nielsen L, Khurana R, Coats A, Frokjaer S, Brange J, Vyas S, Uversky VN, Fink AL. 2001. Effect of environmental factors on the kinetics of insulin fibril formation: Elucidation of the molecular mechanism. Biochemistry 40(20): 6036–6046.
  • Nolting B. 1999. Protein folding kinetics: Biophysical methods. Berlin: Springer-Verlag.
  • Oosawa F, Asakura S. 1975. Thermodynamics of the polymerization of proteins. In: HoreckerB, KaplanNO, MarmurJ, SheragaH, editors. London: Academic Press.
  • Pallitto MM, Murphy RM. 2001. A mathematical model of the kinetics of β-amyloid fibril growth from the denatured state. Biophys J 81(3): 1805–1822.
  • Patro SY, Przybycien TM. 1994. Simulations of kinetically irreversible protein structure. Biophysical Journal 66(5): 1274–1289.
  • Philo JS. 2006. Is any measurement method optimal for all aggregate sizes and types? AAPS J 8(3): E564–E571.
  • Pochan DJ, Schneider JP, Kretsinger J, Ozbas B, Rajagopal K, Haines L. 2003. Thermally reversible hydrogels via intramolecular folding and consequent self-assembly of a de novo designed peptide. J Am Chem Soc 125(39): 11802–11803.
  • Powers ET, Powers DL. 2006. The kinetics of nucleated polymerizations at high concentrations: Amyloid fibril formation near and above the “supercritical concentration”. Biophys J 91(1): 122–312.
  • Purohit VS, Middaugh CR, Balasubramanian SV. 2006. Influence of aggregation on immunogenicity of recombinant human Factor VIII in hemophilia A mice. J Pharm Sci 95(2): 358–371.
    Direct Link:
  • Randolph AD. 1965. The mixed suspension crystallizer as a concept in crystallizer design. AIChE Journal 11(3): 424–430.
    Direct Link:
  • Randolph AD, Larson MA. 1962. Transient and steady-state size distributions in continuous mixed suspension crystallizers. AIChE Journal 8: 639–645.
    Direct Link:
  • Randolph AD, Larson MA. 1965. Analog simulation of dynamic behavior in a mixed crystal suspension. Chemical Engineering Progress, Symposium Series 61(55): 147–154.
  • Remmele RL, Jr., Bhat SD, Phan DH, Gombotz WR. 1999. Minimization of recombinant human Flt3 ligand aggregation at the Tm plateau: A matter of thermal reversibility. Biochemistry 38(16): 5241–5247.
  • Roberts CJ. 2003. Kinetics of irreversible protein aggregation: Analysis of extended Lumry-Eyring models and implications for predicting protein shelf life. J Phys Chem B 107(5): 1194–1207.
  • Roberts CJ. 2006. Non-native protein aggregation: Pathways, kinetics, and shelf-life prediction. In: MurphyRM, TsaiA, editors. Misbehaving proteins: Protein (mis)folding, aggregation, and stability. New York: Springer. pp. 17–46.
  • Roberts CJ, Darrington RT, Whitley MB. 2003. Irreversible aggregation of recombinant bovine granulocyte-colony stimulating factor (bG-CSF) and implications for predicting protein shelf life. J Pharm Sci 92(5): 1095–1111.
    Direct Link:
  • Rosenberg AS. 2006. Effects of protein aggregates: An immunologic perspective. AAPS J 8(3). www.aapsj.org/view.asp?art=aapsj080359 (online only).
  • Ross CA, Poirier MA. 2004. Protein aggregation and neurodegenerative disease. Nat Med 10(Suppl): S10–S17.
  • Sanchez-Ruiz JM. 1992. Theoretical analysis of Lumry-Eyring models in differential scanning calorimetry. Biophys J 61(4): 921–935.
  • Sanchez-Ruiz JM, Lopez-Lacomba JL, Cortijo M, Mateo PL. 1988. Differential scanning calorimetry of the irreversible thermal denaturation of thermolysin. Biochemistry 27(5): 1648–1652.
  • Sasahara K, Naiki H, Goto Y. 2006. Exothermic effects observed upon heating of beta2-microglobulin monomers in the presence of amyloid seeds. Biochemistry 45(29): 8760–8769.
  • Speed MA, King J, Wang DIC. 1997. Polymerization mechanism of polypeptide chain aggregation. Biotechnol Bioeng 54(4): 333–343.
    Direct Link:
  • St John RJ, Carpenter JF, Randolph TW. 1999. High pressure fosters protein refolding from aggregates at high concentrations. Proc Natl Acad Sci USA 96(23): 13029–13033.
  • Stefani M, Dobson CM. 2003. Protein aggregation and aggregate toxicity: New insights into protein folding, misfolding diseases and biological evolution. J Mol Med 81(11): 678–699.
  • Tartaglia GG, Cavalli A, Pellarin R, Caflisch A. 2005. Prediction of aggregation rate and aggregation-prone segments in polypeptide sequences. Protein Sci 14(10): 2723–2734.
    Direct Link:
  • Thirumalai D, Klimov DK, Dima RI. 2003. Emerging ideas on the molecular basis of protein and peptide aggregation. Curr Opin Struct Biol 13(2): 146–159.
  • Thirumangalathu R, Krishnan S, Brems DN, Randolph TW, Carpenter JF. 2006. Effects of pH, temperature, and sucrose on benzyl alcohol-induced aggregation of recombinant human granulocyte colony stimulating factor. J Pharm Sci 95(7): 1480–1497.
    Direct Link:
  • Tobler SA, Holmes BW, Cromwell ME, Fernandez EJ. 2004. Benzyl alcohol-induced destabilization of interferon-gamma: A study by hydrogen-deuterium isotope exchange. J Pharm Sci 93(6): 1605–1617.
    Direct Link:
  • Uversky VN, Fink AL. 2004. Conformational constraints for amyloid fibrillation: The importance of being unfolded. Biochim Biophys Acta 1698(2): 131–153.
  • Wang W. 2005. Protein aggregation and its inhibition in biopharmaceutics. Int J Pharm 289(1–2): 1–30.
  • Webb JN, Webb SD, Cleland JL, Carpenter JF, Randolph TW. 2001. Partial molar volume, surface area, and hydration changes for equilibrium unfolding and formation of aggregation transition state: High-pressure and cosolute studies on recombinant human IFN-γ. Proc Natl Acad Sci USA 98(13): 7259–7264.
  • Webb SD, Cleland JL, Carpenter JF, Randolph TW. 2003. Effects of annealing lyophilized and spray-lyophilized formulations of recombinant human interferon-γ. J Pharm Sci 92(4): 715–729.
    Direct Link:
  • Weijers M, Barneveld PA, Cohen Stuart MA, Visschers RW. 2003. Heat-induced denaturation and aggregation of ovalbumin at neutral pH described by irreversible first-order kinetics. Protein Sci 12(12): 2693–2703.
    Direct Link:
  • Whiteley EM, Hsu T-A, Betenbaugh MJ. 1997. Modeling assembly, aggregation, and chaperoning of immunoglobulin G production in insect cells. Biotechnol Bioeng 56(1): 106–116.
    Direct Link:
  • Wiseman RL, Powers ET, Kelly JW. 2005. Partitioning conformational intermediates between competing refolding and aggregation pathways: Insights into transthyretin amyloid disease. Biochemistry 44(50): 16612–16623.
  • Wood SJ, Wypych J, Steavenson S, Louis J-C, Citron M, Biere AL. 1999. α-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. J Biol Chem 274(28): 19509–19512.
  • Zale SE, Klibanov AM. 1983. On the role of reversible denaturation (unfolding) in the irreversible thermal inactivation of enzymes. Biotechnol Bioeng 25(9): 2221–2230.
    Direct Link:
Get PDF (319K)